Shanxi Zhendong Ant Biopharmaceutical Co., Ltd. is located in the Jinzhong Economic and Technological Development Zone, Shanxi Province. It is a high -tech enterprise that is mainly engaged in new drug research, development, production and sales of "digestive tract drugs".In October 1994, it was the largest foreign -funded pharmaceutical company in the province. It registered 50 million yuan and more than 500 employees.In May 2011, Ante joined Zhendong and became a wholly -owned subsidiary of Zhendong Group.
Since its establishment, the Ante people have adhered to the corporate purpose of "focusing on Ankang and creating special effects", and have made the courage to innovate and make progress have made their due contributions to the development of Shanxis economy and pharmaceutical undertakings, and achieved good economic and social benefits.With widespread attention from all walks of life, the company has successively won the May 1st Labor Awards, Medal, and Collective First -class merits of the Shanxi Province. In 2007, the Shanxi Provincial Government was listed as a key pharmaceutical enterprise supported by the "Eleventh Five -Year Plan".
In terms of management, the company is committed to the establishment of the "Ann features" management system to create a service -oriented management culture. The companys first "SSI" management model is Standardization, Specialization, and Innovation.Clarify the responsibilities of each position, formulate standardized workflow and quantitative assessment standards, and indicate the development direction of professional and innovative development for each employee.Dynamic management of resources.The model innovation has exploded huge energy. Under the overall downturn of the pharmaceutical industry, the companys three -year performance growth rate exceeded 30%, laying the foundation for the overall double performance after the Ming Dynasty.
Culturally, the company is committed to the establishment of a sense of justice, healthy, and harmonious corporate culture. In three years, the company has completed the "focusing on the interests of corporate interests, with team collaboration first, fair competition, and dedication to suffering.The shaping of Ante moral culture, which is proud of, strictly adheres to institutional standards, and active learning innovation ", has formed a cultural atmosphere of" professional first and active learning "in the company.The role of party organizations and trade unions in enterprises, inheriting the excellent tradition of learning the party, and giving play to the pioneering role of party members in employees.
In the construction of the team, implementing the strategy of building a talent and prospering enterprise, creating an atmosphere of "respect for talents and reorganization" in the company.Based on the model, the supporting manpower evaluation system is improved, and the career development of employees to design and adapt to the growth of enterprises.Knowledge and professional composite talents have become the main force in the development of Ante.
In terms of products, after many years of operation, the company has formed four series of products: heartbrain, nerves, and external use of digestive tract drugs. It has eight national new drugs.Over one billion yuan, the "Ante Collagen Capsule Capsule" was rated as a well -known trademark in Shanxi Province; the "Ballow Nitrogen Tablets" filled the gap in the field of domestic ulcerative colitis and was included in the national torch plan project;The "safflower injection" has been guaranteed through craftsmanship, and its quality is guaranteed. Sales have doubled every year. The company has become the largest production and sales enterprise in the country in the country.
在研发上，公司致力于具有“自主知识”产权创新药物的研究与开发，以省级技术中心为平台，建有完善的研发体系，拥有一支专门从事医药研究和产品开发的专业团队，与The domestic well -known houses have a wide and deep cooperative relationship. At present, the two independent innovation projects of the companys "compound collagen fruit gel preparations" and "Bali nitrogen enema preparation" have obtained the national patent, entering the new pharmaceutical research and development stage, of which compound colloidaPointing agent is a national first -class drug.Researching products have become the motivation support for the companys re -development.
In terms of marketing, the company adheres to the marketing strategy of clinical and retail development. Based on the "clinical" advantage, for the development rules of different stages of products, the company has completed the "academic" as its core, the product is from the clinical ladder to OCT to OCT.The market transfer product marketing strategic layout. The company has offices in the 30 provincial autonomous regions of the country. It has a high -quality professional marketing team and has stable in more than 1,000 hospitals and top 20 well -known business in China.Cooperation relationships, nearly a thousand experts provide academic support for the company.
In terms of production, the company has a modern pharmaceutical production base that meets the GMP standard. All facilities and equipment have reached the leading domestic level.The drug production line is complete and reasonable product dosage form.
The era of pharmaceutical development has arrived. For Ante, the career has just begun. For the future of the company, we are full of confidence. Our goal is more clear, that is, "casting an Ant century -old enterprise and creating the first brand of national digestive tract."